ImmuneBridge

Developing allogeneic immunotherapies for cancer using umbilical cord blood-derived immune stem cells

[Suffiyan Malik @suffiyanmalikk]

Tuesday drop @WeThe_Builders, featuring, @omri_drory, General Partner, @NFX, a $1.4B AUM pre-seed and seed stage venture capital firm that invests in tech startups across various sectors, focusing on fostering network effects and defensible competitive advantages. They seek out companies in fields like AI, biotech, fintech, SaaS, marketplaces, and crypto.

He started out conducting research in Israel’s intelligence corps to pipetting at Stanford labs. Exited Genome Compiler to @TwistBioscience ($2B market cap, NASDAQ: TWST). Launching a pre-seed venture fund called TechBio which lead him to his role at NFX.

Worth reading, Omri’s “Race to 160” blog. This actually makes sense as the human lifespan has double in the last few centuries from ~40 to ~80 and up from ~20 from about 5,000 years ago - Omri discusses this in the pod.

He's on the board of/invested/advisor in some of the following companies: @immunebridge @Powerhouse_Bio, @permanencebio, Radar Therapeutics, TwoStep Therapeutics, @ZipBio_Inc, @centivax, @mammothbiosci. We will be covering Trevor @ Mammoth in a future episode, stay tuned!

Highlights & Timestamps:

(00:00) - Introduction
(00:55) - Early Life, Military, PhD
(04:00) - Learnings from the Military
(07:10) - Life at Stanford and Entrepreneurship
(11:56) - Recruiting friends to start a company
(13:30) - Race to 160
(18:05) - ABCD plan for aging
(26:59) - Companies actively working towards solving aging
(31:22) - Singularity and Ray Kurzweil
(33:12) - What it takes to be a founder
(40:12) - People investing vs Technology investing
(45:00) - DNA of a founder
(48:11) - The initial spark to become an entrepreneur
(51:37) - Agency, Risk Appetite and Perseverance
(55:21) - Network Effects
(1:04:47) - Breakthrough Innovation
(1:09:41) - Storytelling and authenticity
(1:14:58) - Role Models
(1:18:11) - Rapid fire and closing thoughts

[ImmuneBridge @immunebridge]

We are so excited to be hosting our first #SFTechWeek event! If you want to save cell therapy, or are curious how AI can help us achieve that, register here: https://t.co/pJnyr9OvLF

[Katia Ameri 🗽 #NYTechWeek @KatiaAmeri]

🎉 Big news! The official calendar of events for #SFTechWeek and #LATechWeek is now LIVE!

And thrilled to announce that this is officially our BIGGEST Tech Week, ever!

- 850+ events 🤯
- San Francisco: Oct 7-13 🌉
- Los Angeles: Oct 14-20 🌴

Link to register below to see all events👇

[ImmuneBridge @immunebridge]

Members of our NK R&D and leadership teams have landed in Norway for #NK2023! Catch us at poster A-077 or track us down to chat about all things NK immunogenomics, translation, and manufacturing!

[ImmuneBridge @immunebridge]

We had a blast speaking at the @HansonWade Innate Killer Summit! Thanks for inviting us and organizing such a wonderful event. See you next year!

[ImmuneBridge @immunebridge]

@SNI_NKMeeting @LabFehniger @LabWaggoner @MalmbergLab We’ve had a great time at #NK2022, getting steeped in the science of what makes NK cells tick and connecting to the innate crew. We’re looking for NK wranglers excited to part of the core R&D team at ImmuneBridge. Join us! https://t.co/vAs8ctJgGv